← Open Payments lookup

JULIE CONRAD: Open Payments

NPI 1639698822 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,911 in 214 payments from 17 companies in 2025. Trend: 2023 $2,932 · 2024 $3,088 · 2025 $3,911

Food & beverage: $3,911
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.37$796
Teva Pharmaceuticals USA, Inc.38$443
Otsuka America Pharmaceutical, Inc.15$431
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$322
Alkermes, Inc.12$311
Janssen Pharmaceuticals, Inc14$298
Vanda Pharmaceuticals Inc.12$294
ABBVIE INC.30$268
Axsome Therapeutics, Inc.8$218
E.R. Squibb & Sons, L.L.C.12$211

Products named: INGREZZA, REXULTI, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, UZEDY, Auvelity, AUSTEDO XR.

Industry payments across FL — which companies pay providers there.